News
While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...
4h
Asianet Newsable on MSNNovo Nordisk Gains Ground In Obesity Race As Amycretin, Wegovy Show Significant Weight LossIn addition, the company reported a 21% mean weight loss in a higher dose cohort of the 7.2 mg formulation of Wegovy ...
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...
At a time when Novo Nordisk has appeared to be slipping behind rival Eli Lilly and its blockbuster Zepbound (tirzepatide) in ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results